1. 5PSQ-012 Are 12 months of treatment with monoclonal antibodies sufficient for migraine attack prevention?. (23rd March 2022) Authors: Fresan, D; Lacalle, E; Calvo, M; Tejada, D; Albalat Torres, A; Ortega, I; Pino, A; Erdozain, S; Larrayoz, B; Sarobe, M Journal: European journal of hospital pharmacy Issue: Volume 29(2022)Supplement 1 Page Start: A121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗